Loading clinical trials...

COMPLETED

Long-Term Follow-up Safety of Clonidine Micropellets

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

NCT03776318•Sollis Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subject who have successfully completed all STX-015-18-01 study related activities, are reconfirmed to be eligible and have signed informed consent to participate.

Exclusion Criteria

•Subjects who, in the opinion of the investigator, have demonstrated significant non-compliance with STX-015-18-01 study procedures.
•Subjects who were unblinded to their treatment in STX-015-18-01 study.

Locations (25)

Sollis Clinical Study Site 36

Mobile, Alabama, United States

Sollis Clinical Study Site 44

Phoenix, Arizona, United States

Sollis Clinical Study Site 40

Tucson, Arizona, United States

Sollis Clinical Study Site 49

Rancho Mirage, California, United States

Sollis Clinical Study Site 30

Washington D.C., District of Columbia, United States

Sollis Clinical Study Site 35

Fort Lauderdale, Florida, United States

Sollis Clinical Study Site 38

Miami, Florida, United States

Sollis Clinical Study Site 12

Bloomington, Illinois, United States

Sollis Clinical Study Site 13

Chicago, Illinois, United States

Sollis Clinical Study Site 14

Kansas City, Kansas, United States

Key Dates

Start Date

November 15, 2018

Primary Completion Date

January 22, 2021

Completion Date

May 31, 2021

Last Updated

October 6, 2023

Enrollment

100

ACTUAL participants

Conditions

Lumbosacral Radiculopathy

Interventions

Long-Term Safety Follow-up

DRUG

Augmented Posterior Oblique Sling Activation on Lumbopelvic Recruitment Pattern in Lumbosacral Radiculopathy

NCT06558383

Lumbosacral Radiculopathy

View study

COMPLETEDPHASE2

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

NCT06176196

Painful Lumbosacral Radiculopathy

View study

NOT_YET_RECRUITINGNA

Effect of Kinetic Control in Lumbosacral Radiculopathy.

NCT07079202

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 6, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Long-Term Follow-up Safety of Clonidine Micropellets

Inclusion Criteria

Exclusion Criteria

Augmented Posterior Oblique Sling Activation on Lumbopelvic Recruitment Pattern in Lumbosacral Radiculopathy

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Effect of Kinetic Control in Lumbosacral Radiculopathy.

Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Effects of Multimodal Physical Therapy in Patients With Lumbosacral Radiculopathy

Effects of Mackenzie Extension and William Flexion Exercises in Lumbo-sarcal Radiculopathy